Acerus Pharmaceuticals USA, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Acerus Pharmaceuticals USA, LLC
Quantité totale PI 13
Rang # Quantité totale PI 119 950
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 197 659
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

7 0
3 0
0 0
3
 
Dernier brevet 2025 - Safe desmopressin administration
Premier brevet 2003 - Pharmaceutical compositions incl...
Dernière marque 2014 - NOCTIVA
Première marque 2011 - PACSERA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Safe desmopressin administration. Disclosed is a family of intranasal spray dispensers for admin...
2023 Invention Intranasal desmopressin administration. Disclosed is a family of intranasal spray dispensers for...
2022 Invention Safe desmopressin administration. Disclosed is a family of intranasal spray dispensers for admini...
2017 Invention Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor...
2015 Invention Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor...
2014 Invention Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibito...
P/S Pharmaceutical preparations for the treatment of nocturia.
2011 P/S Pharmaceutical preparations for the treatment of nocturia; none of the aforesaid goods containing...
2009 Invention Safe desmopressin administration.
Disclosed is a family of intranasal spray dispensers...
2008 Invention Pharmaceutical compositions including low dosages of desmopressin. The present invention is direc...